BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹42.02 | ₹36.10 | ₹30.43 | ₹24.60 | ₹11.61 |
What is the latest Earnings Per Share (EPS) of BETA DRUGS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹42.02 |
| Mar2025 | ₹36.10 |
| Mar2024 | ₹30.43 |
| Mar2023 | ₹24.60 |
| Mar2022 | ₹11.61 |
How is Earnings Per Share (EPS) of BETA DRUGS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹42.02 | 16.40 | |
| Mar2025 | ₹36.10 | 18.63 | |
| Mar2024 | ₹30.43 | 23.70 | |
| Mar2023 | ₹24.60 | 111.89 | |
| Mar2022 | ₹11.61 | - | |
Compare Earnings Per Share (EPS) of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,195.5 Cr | 15% | -9.6% | 6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.1% | -6.5% | 3.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,780.0 Cr | -0.2% | -5.5% | 35.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,828.0 Cr | 0.4% | -8.2% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,305.0 Cr | 1.7% | -2% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,759.0 Cr | 4.9% | 7.7% | -2.5% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 15% |
-9.6% |
6% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
You may also like the below Video Courses